Colombia face-off with Novartis, U.S. lawmakers over cancer drug pricing (May 18, 2016)
latinamericadailybriefing.substack.com
Colombia is facing off against international pharmaceutical giant Novartis. The government has given the world's biggest drugmaker a few weeks to lower prices on a leukemia drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.
Colombia face-off with Novartis, U.S. lawmakers over cancer drug pricing (May 18, 2016)
Colombia face-off with Novartis, U.S…
Colombia face-off with Novartis, U.S. lawmakers over cancer drug pricing (May 18, 2016)
Colombia is facing off against international pharmaceutical giant Novartis. The government has given the world's biggest drugmaker a few weeks to lower prices on a leukemia drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.